starting dose tirzepatide Dosage Guide: Doses to Maintenance Tirzepatide Dosing & Titration Guide

The choice between Retatrutide vs tirzepatide could become clearer if Retatrutide is eventually approved

Research has identified these alarming vision-related risks associated with GLP-1 medications: Sudden irreversible vision loss: NAION strikes without warning, often discovered upon waking, causing blurry or dim vision that progresses to immediate and permanent partial or complete blindness in the affected eye with no possibility of restoration Elevated risk across multiple studies: Beyond the Harvard findings showing 4-7 fold increased risk, a University of Southern Denmark study examining over 424,000 patients found weekly semaglutide users faced 2.19 times higher NAION risk European regulatory recognition: In June 2025, the European Medicines Agency officially recognized NAION as a possible side effect of semaglutide medications, marking formal acknowledgment by international regulators Complete absence of treatment options: Medical science currently offers no cure, no effective treatment, and no way to reverse NAION-related vision damage, leaving patients with permanent disability The permanent and irreversible nature of NAION-related optic nerve damage distinguishes these injuries from other complications that may resolve after discontinuing medication

At Perfect B, this stack is chosen for patients whose primary goal is body recomposition alongside physical recovery

These symptoms may indicate pancreatitis, gastroparesis (severely delayed stomach emptying), or another condition that requires dose adjustment or medication discontinuation

Young men in a 40% calorie deficit who consumed 2.4 grams of protein per kilogram per day (using whey protein supplementation post-exercise) while performing resistance training and high-intensity interval training six days per week actually gained lean body mass while losing fat